You are here

Eagle Pharmaceuticals

With another FDA nod, Eagle's Pemfexy gets up to speed with Lilly's Alimta

Fierce Pharma

Mon, 12/19/22 - 11:02 am

Eagle Pharmaceuticals

non-small cell lung cancer

FDA Review: Phanes, Pfizer, GSK and More

BioSpace

Fri, 10/14/22 - 10:38 am

Eagle Pharmaceuticals

Galactin Therapeutics

Gilead Sciences

scPharmaceuticals

Endo loses Vasostrict patent battle as sales take a hit from generics

Endpoints

Sun, 08/21/22 - 09:43 pm

Endo International

Eagle Pharmaceuticals

Eagle Announces Acquisition of Acacia in Strategic Good Fit

BioSpace

Mon, 03/28/22 - 10:11 am

Eagle Pharmaceuticals

Additional exclusivity for a cancer treatment could cost the public $3 billion, analyst says

Endpoints

Mon, 02/25/19 - 11:32 pm

Eagle Pharmaceuticals

Eagle Receives Orphan Drug Designation for Bendeka

CP Wire

Mon, 07/9/18 - 10:52 am

Eagle Pharmaceuticals

Eagle Receives Orphan Drug Designation for Bendeka

Mon, 07/9/18 - 09:32 am

Eagle Pharmaceuticals

Eagle Pharmaceuticals Receives New Patent for Bendeka Configure

CP Wire

Tue, 07/3/18 - 10:15 am

Eagle Pharmaceuticals

Teva Pharmaceuticals

FDA rejects Eagle Pharma's reformulated Angiomax

Fierce Biotech

Mon, 03/21/16 - 09:02 am

Eagle Pharmaceuticals

The Top 5 Best Performing Biotech Stocks of 2015

Motley Fool

Sat, 01/2/16 - 10:27 am

Eagle Pharmaceuticals

Heron Therapeutics

The Best Biotech Stocks in 2015

Motley Fool

Mon, 12/28/15 - 09:58 am

Eagle Pharmaceuticals

2nd Half Of 2014 Biotechnology Catalysts: Part 1

Seeking Alpha

Tue, 05/27/14 - 11:53 am

BioDelivery Sciences

Eagle Pharmaceuticals

Navidea Biopharmaceuticals

Trimel Pharmaceuticals

Biotechs pocket another $115M as the IPO boom thunders on

Fierce Biotech

Wed, 02/12/14 - 11:59 am

Eagle Pharmaceuticals